• linkedin
  • Increase Font
  • Sharebar

    Every New FDA Drug Approval in 2017

    The last 12 drugs approved in the year, along with the other 34.

     

    Fasenra image

    Fasenra (benralizumab), AstraZeneca

    Indications: Add-on maintenance treatment for patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

    Dosage: By subcutaneous injection, 30 mg every 4 weeks for the first 3 doses, followed by once every 8 weeks thereafter.

    Contraindications: Known hypersensitivity to benralizumab or excipients.

    Click here to read the full label

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available